Neo Ivy Capital Management’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,054
Closed -$300K 467
2025
Q4
$300K Buy
+1,054
New +$330K 0.05% 231
2024
Q3
Sell
-524
Closed -$106K 369
2024
Q2
$106K Buy
+524
New +$94.4K 0.02% 204
2022
Q2
Sell
-120
Closed -$32K 569
2022
Q1
$32K Buy
+120
New +$29.5K 0.03% 405
2021
Q2
Sell
-211
Closed -$55K 573
2021
Q1
$55K Sell
211
-258
-55% -$69.1K 0.06% 320
2020
Q4
$120K Buy
+469
New +$116K 0.13% 236
2020
Q1
Sell
-2,540
Closed -$435K 526
2019
Q4
$435K Buy
2,540
+96
+4% +$16K 0.5% 88
2019
Q3
$377K Buy
2,444
+2,443
+244,300% +$343K 0.25% 169
2019
Q2
$0 Sell
1
-61
-98% -$6.25K ﹤0.01% 380
2019
Q1
$5K Buy
+62
New +$5.31K ﹤0.01% 271

Other funds holding PODD

Neo Ivy Capital Management's PODD Position: Q1 2026 in Review

Neo Ivy Capital Management sold out of Insulet (PODD) in Q1 2026, closing a stake of 1,054 shares — an estimated $300K sold.

Neo Ivy Capital Management first reported a position in PODD in Q1 2019 and held it in 9 quarters. The position peaked at $435K in Q4 2019. 784 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • Neo Ivy Capital Management reported no remaining Insulet position as of Q1 2026 after selling out during the quarter.
  • Neo Ivy Capital Management sold 1,054 Insulet shares in Q1 2026, an estimated $300K.
  • Neo Ivy Capital Management first reported a position in Insulet in Q1 2019 and held it in 9 quarters.
  • Neo Ivy Capital Management's Insulet position peaked at $435K in Q4 2019.
  • 784 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on Neo Ivy Capital Management's 13F filing for Q1 2026, filed 15 May 2026.